Pnc-Financial-Services-Group

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-09
Total Holdings
9,326
Total Value
66648048783
Accession Number
0000950123-25-004380
Form Type
13F-HR
Manager Name
Pnc-Financial-Services-Group
Data Enrichment
79% identified
7,342 identified1,984 unidentified

Holdings

9,326 positions • $66.6B total value
Manager:
Search and click to pin securities to the top
FIRST TRUST SENIOR FLOATING RATE INCOME FUND II
Shares:7
Value:$71
% of Portfolio:0.0% ($71/$66.6B)
European Wax Center, Inc.
Shares:18
Value:$71
% of Portfolio:0.0% ($71/$66.6B)
BlackSky Technology Inc.
Shares:9
Value:$70
% of Portfolio:0.0% ($70/$66.6B)
ALX ONCOLOGY HOLDINGS INC
Shares:112
Value:$70
% of Portfolio:0.0% ($70/$66.6B)
426897401
Shares:156
Value:$67
% of Portfolio:0.0% ($67/$66.6B)
292812104
Shares:6
Value:$67
% of Portfolio:0.0% ($67/$66.6B)
Playa Hotels & Resorts N.V.
Shares:5
Value:$67
% of Portfolio:0.0% ($67/$66.6B)
E2open Parent Holdings, Inc.
Shares:31
Value:$62
% of Portfolio:0.0% ($62/$66.6B)
Generation Bio Co.
Shares:143
Value:$58
% of Portfolio:0.0% ($58/$66.6B)
Traeger, Inc.
Shares:32
Value:$54
% of Portfolio:0.0% ($54/$66.6B)
Absci Corp
Shares:21
Value:$53
% of Portfolio:0.0% ($53/$66.6B)
Waldencast plc
Shares:16
Value:$48
% of Portfolio:0.0% ($48/$66.6B)
Cabaletta Bio, Inc.
Shares:33
Value:$46
% of Portfolio:0.0% ($46/$66.6B)
Verrica Pharmaceuticals Inc.
Shares:103
Value:$46
% of Portfolio:0.0% ($46/$66.6B)
Verve Therapeutics, Inc.
Shares:10
Value:$46
% of Portfolio:0.0% ($46/$66.6B)
889115101
Shares:3
Value:$46
% of Portfolio:0.0% ($46/$66.6B)
Alto Neuroscience, Inc.
Shares:21
Value:$45
% of Portfolio:0.0% ($45/$66.6B)
05156X850
Shares:10
Value:$44
% of Portfolio:0.0% ($44/$66.6B)
EGAIN Corp
Shares:9
Value:$44
% of Portfolio:0.0% ($44/$66.6B)
Orion Properties Inc.
Shares:20
Value:$43
% of Portfolio:0.0% ($43/$66.6B)